Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review
- 1 June 2017
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 114, 53-62
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Progress in treatments for colorectal cancer peritoneal metastases during the years 2010–2015. A systematic reviewCritical Reviews in Oncology/Hematology, 2016
- Predictors of Progression in High-Grade Appendiceal or Colorectal Peritoneal Carcinomatosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyAnnals of Surgical Oncology, 2014
- Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Affect Long-term Outcome of Patients With Peritoneal Metastases From Colorectal CancerDiseases of the Colon & Rectum, 2014
- Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal CarcinomatosisAnnals of Surgical Oncology, 2014
- Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancerJournal of Surgical Oncology, 2014
- Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP DatabaseAnnals of Surgical Oncology, 2013
- Identification of a Subgroup of Patients at Highest Risk for Complications After Surgical Cytoreduction and Hyperthermic Intraperitoneal ChemotherapyAnnals of Surgery, 2012
- Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort studyEuropean Journal of Surgical Oncology, 2012
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC TrialJournal of Clinical Oncology, 2009
- Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinomaBritish Journal of Cancer, 1999